anti tumor powder egfr inhibitor cas 1213269-23-8 WZ4002

WZ4002

WZ4002 is EGFR Inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib. WZ4002 has a basic chemical framework (covalent pyrimidine) which is different from that of other EGFR Inhibitors. This agent is 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wildtype EGFR, than quinazoline-based EGFR inhibitors (HKI-272 and CL-387,785) in vitro.

Contact us if you need more details on Wz4002 Clinical Trial. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about Wz4002 Azd9291、Egfr Inhibitor. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Anticancer APIS